The androgen receptor (AR) is a ligand-activated transcription factor that mediates the effects of androgenic hormones, primarily testosterone and dihydrotestosterone (DHT). Beyond its well-established role in male sexual development and prostate biology, the AR is increasingly recognized for its important functions in the central nervous system, including neuroprotection, cognitive function, and motor control. Mutations in the AR gene cause spinal and bulbar muscular atrophy (SBMA), a progressive neurodegenerative disorder.<sup>[1]</sup>
The androgen receptor (AR) is a ligand-activated transcription factor that mediates the effects of androgenic hormones, primarily testosterone and dihydrotestosterone (DHT). Beyond its well-established role in male sexual development and prostate biology, the AR is increasingly recognized for its important functions in the central nervous system, including neuroprotection, cognitive function, and motor control. Mutations in the AR gene cause spinal and bulbar muscular atrophy (SBMA), a progressive neurodegenerative disorder.<sup>[1]</sup>
Structure
The AR protein contains several distinct functional domains:
N-Terminal Domain (NTD; residues 1-537)
The intrinsically disordered N-terminal domain contains:
Activation Function 1 (AF-1): Transactivation region mediating transcriptional activation
Polyglutamine (CAG) tract: Normal length 10-36 repeats; expansion causes SBMA
Recognition helix contacts androgen response elements (AREs) in DNA
Dimerization interface
Hinge Region (residues 646-670)
Nuclear localization signal (NLS)
Linking region between DBD and LBD
Ligand-Binding Domain (LBD; residues 671-919)
steroid-binding pocket with high affinity for DHT (Kd ~0.1 nM)
Contains Activation Function 2 (AF-2)
Heat shock protein (HSP90) binding site in unliganded state
Normal Function
Androgen Signaling
Upon binding of DHT or testosterone, the AR undergoes a conformational change, dissociates from HSP90, dimerizes, and translocates to the nucleus where it binds to androgen response elements (AREs) in target gene promoters to regulate transcription.<sup>[2]</sup>
Key target genes include:
PSA (KLK3): Prostate-specific antigen
TMPRSS2: Transmembrane protease
FKBP5: Immunophilin chaperone
neuronal genes: Including those involved in synaptic plasticity
Neuroprotective Effects
In the central nervous system, AR signaling exerts neuroprotective effects through:
Anti-apoptotic signaling: Upregulation of Bcl-2 family proteins
Antioxidant defense: Enhancement of glutathione peroxidase activity
Synaptic plasticity: Regulation of [NMDA receptor](/entities/nmda-receptor) subunit composition
Myelin maintenance: Support of oligodendrocyte function
Cognitive Function
AR in the [hippocampus](/brain-regions/hippocampus) and prefrontal [cortex](/brain-regions/cortex) regulates:
Spatial memory consolidation
Executive function
Mood and behavior (through limbic system modulation)
Role in Disease
Spinal and Bulbar Muscular Atrophy (SBMA)
SBMA, also known as Kennedy's disease, is an X-linked recessive neuromuscular disorder caused by CAG repeat expansion in the AR gene (40-62 repeats). The disease manifests in adulthood with:
Progressive proximal muscle weakness: Starting in shoulder and pelvic girdle
Impaired [autophagy](/entities/autophagy): Reduced clearance of damaged proteins
The mutant AR forms nuclear aggregates that sequester transcription factors and chaperones, disrupting normal gene expression programs essential for motor neuron survival.<sup>[3]</sup>
Alzheimer's Disease
Androgen deficiency may contribute to AD pathogenesis:
Low testosterone levels associated with increased AD risk in men<sup>[4]</sup>
AR signaling dysfunction in AD brains
Testosterone supplementation studies show mixed results on cognitive outcomes
Parkinson's Disease
AR may modify PD risk and progression:
Androgen deprivation therapy associated with increased PD risk
AR interactions with [alpha-synuclein](/proteins/alpha-synuclein) aggregation
Gender differences in PD prevalence (higher in men)
Prostate Cancer (Brain Metastases)
AR expression in brain metastases from prostate cancer can influence:
Metastatic colonization
Treatment resistance to androgen deprivation therapy
Gene silencing: ASO and siRNA approaches targeting mutant AR
Androgen modulation: Leuprolide to reduce ligand availability
Androgen Therapy in Neurodegeneration
Testosterone replacement trials in age-related cognitive decline
Selective androgen receptor modulators (SARMs) for neuroprotection
DHEA supplementation
Key Publications
[La Spada et al., Nature (1991)](https://pubmed.ncbi.nlm.nih.gov/1848786/): Discovery of AR CAG expansion causing SBMA
[Kumar et al., J Mol Endocrinol (2014)](https://pubmed.ncbi.nlm.nih.gov/24624353/): Androgen receptor structure and function
[Pennuto et al., Nat Rev Neurol (2015)](https://pubmed.ncbi.nlm.nih.gov/26358738/): Pathogenesis and therapy in SBMA
[Pike et al., J Neurosci (2009)](https://pubmed.ncbi.nlm.nih.gov/19261856/): Testosterone and brain function in AD
[Finch et al., Neurobiol Aging (2014)](https://pubmed.ncbi.nlm.nih.gov/24064162/): Androgens and alpha-synuclein in PD models
References
<sup>[1]</sup> [Spinal and bulbar muscular atrophy: Pathogenesis and treatment (2015)](https://pubmed.ncbi.nlm.nih.gov/26358738/) <sup>[2]</sup> [Androgen receptor mechanisms in peripheral and central nervous system (2014)](https://pubmed.ncbi.nlm.nih.gov/24624353/) <sup>[3]</sup> [Molecular mechanisms of polyglutamine toxicity in SBMA (2009)](https://pubmed.ncbi.nlm.nih.gov/19158860/) <sup>[4]</sup> [Testosterone and risk of Alzheimer's disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19261856/) <sup>[5]</sup> [HDAC inhibition as therapeutic strategy in SBMA (2018)](https://pubmed.ncbi.nlm.nih.gov/29463547/)